BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines operating Lease Right-of-Use (ROU) Assets ($M) ($M)
Form 10-Q / 10-K Leases Note (XBRL)
Latest, Q2 2026
146
Period ended Jun 30, 2026
Change on a year earlier
+0.1%
146 in Q2 2025
History
32 quarters
Since Q4 2017
Sources
31
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up operating lease right-of-use (rou) assets ($m)
- Operating Lease Liabilities — Current ($M)21.9 · Q2 2026
- Operating Lease Liabilities — Noncurrent ($M)48.2 · Q2 2026
- Operating Lease Liabilities — Total ($M)–
- Total Lease Cost ($M)–
- Operating Cash Flows Paid for Operating Leases ($M)–
- ROU Assets Obtained in Exchange for Operating Lease Liabilities ($M)–
- Operating Lease Weighted-Average Discount Rate (%)–
- Undiscounted Future Operating Lease Payments — Total ($M)–
Cite this data
StockData. (2026). BeOne Medicines Operating Lease Right-of-Use (ROU) Assets ($M) ($M), quarterly Q4 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/op_lease_rou
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.